Hjem › Ikke-småcellet lungekreft › Ohio › Toledo
Kliniske studier for Ikke-småcellet lungekreft i Toledo, OH
17 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Toledo (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 2
- Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg · 8 mi unna
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
RekruttererFase 3
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi unna
- ProMedica Flower Hospital, Sylvania · 9 mi unna
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruttererFase 1
- Site 06, Maumee · 9 mi unna
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekruttererFase 3
- Taylor Cancer Research Center, Maumee · 9 mi unna
Pan-tumor MRD Study
RekruttererObservasjonsstudie
- Taylor Cancer Research Center, Maumee · 9 mi unna
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekruttererFase 3
- Research Site, Toledo
- Research Site, Maumee · 9 mi unna
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- Toledo Clinic Cancer Center, Toledo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi unna
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruttererFase 1/2
- Taylor Cancer Research Center, Maumee · 9 mi unna
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Research Site, Maumee · 9 mi unna
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Taylor Cancer Research Center, Maumee · 9 mi unna
GEMINI-NSCLC: NSCLC Biomarker Study
RekruttererObservasjonsstudie
- Taylor Cancer Research Center, Maumee · 9 mi unna
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruttererFase 1/2
- Taylor Cancer Research Center (site 204), Maumee · 9 mi unna
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Toledo
- Eggstokkreft12 studier
- Lungekreft11 studier
- Metastatisk kreft10 studier
- Slag9 studier
- Plateepitelcancer i hode og hals8 studier
- Endometriekreft8 studier
- Melanom8 studier
- Pankreaskreft8 studier
- Prostatakreft7 studier
- Spiserørkreft7 studier
- Iskemisk slag7 studier
- Hjertesvikt7 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.